The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction
Molecular Cell · 2026-03 · 86 (6) · 1116-1133.e8
DOI: 10.1016/j.molcel.2026.01.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026-03. Verfasst von Dominic A Ritacco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Lysosomes, Interferon Type I, Mitochondria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Lysosomal damage is an endogenous danger signal, but its significance for innate immunity and the specific signaling pathways it engages remain unclear. Here, we uncover an immune-inducible pathway that connects lysosomal damage to mitochondrial DNA (mtDNA) efflux and type I IFN production. We find that transient lysosomal damage elicits sub-lethal mitochondrial outer membrane permeabilization (MOMP) via BAK/BAX macropores; however, the inner mitochondrial membrane (IMM) maintains a barrier against wholesale mtDNA release. Priming with type II IFN (IFN-γ) induced the antibacterial factor APOL3, which, upon sensing lysosomal damage, targets mitochondria undergoing MOMP to selectively permeabilize the IMM, enhance mtDNA release, and potentiate downstream cGAS signaling. Biochemical and cellular reconstitution revealed that, analogous to its bactericidal detergent-like mechanism, APOL3 permeabilized the IMM by solubilizing cardiolipin. Our findings illustrate how cells enlist an antibacterial protein to expedite the breakdown of endosymbiosis and facilitate a heightened response to injury and infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: rg3477@cumc.columbia.edu.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NCI NIH HHS
- Office of the Director
- National Cancer Institute
- Columbia University
- National Institutes of Health
Zitieren
APA
Ritacco, D. A., Shahnawaz, H., Oduguwa, A., Hawk, J., Vizcaino, B., Farber, D. L., & Gaudet, R. G. (2026). The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction. Molecular Cell, 86(6), 1116-1133.e8. https://doi.org/10.1016/j.molcel.2026.01.029
Vancouver
Ritacco DA, Shahnawaz H, Oduguwa A, Hawk J, Vizcaino B, Farber DL, et al. The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction. Molecular Cell. 2026;86(6):1116-1133.e8. doi:10.1016/j.molcel.2026.01.029
BibTeX
@article{Ritacco2026,
author = {Ritacco, Dominic A and Shahnawaz, Hamna and Oduguwa, Antonia and Hawk, Jacob and Vizcaino, Brianna and Farber, Donna L and Gaudet, Ryan G},
title = {The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {6},
pages = {1116--1133.e8},
doi = {10.1016/j.molcel.2026.01.029}
}
EUVIMED